Argenx SE
Company · Research and Development in Biotechnology (except Nanobiotechnology) · Belgium
Belgian-Dutch biopharmaceutical company specialising in immunology
- Revenue
- $4.2B
- People
- 1,863
- Parts
- 3
- 3 sources
Updated
Karen Massey
Updated
Karen Massey is chief executive at Argenx SE.
01Roles
Each role as its source states it, with the dates when the source gives them.
- Argenx SE · Chief executive6 May 2026 to nowwikidata.org
02Their organizations
Open one for how it is built: its map, figures and connections.
03About this page
System Atlas lists notable people only in their roles at organizations, and only people with a Wikidata item. It never shows contact details, addresses, birth dates or family. Is this you, or do you act for them? Ask to be taken off and the team reviews it.
Ask to be taken off